Application of transcriptomic and microRNA profiling in the evaluation of potential liver carcinogens

Toxicol Ind Health. 2020 May;36(5):386-397. doi: 10.1177/0748233720922710. Epub 2020 May 18.

Abstract

Hepatocarcinogens are agents that increase the incidence of liver cancer in exposed animals or humans. It is now established that carcinogenic exposures have a widespread impact on the transcriptome, inducing both adaptive and adverse changes in the activities of genes and pathways. Chemical hepatocarcinogens have also been shown to affect expression of microRNA (miRNA), the evolutionarily conserved noncoding RNA that regulates gene expression posttranscriptionally. Considerable effort has been invested into examining the involvement of mRNA in chemical hepatocarcinogenesis and their potential usage for the classification and prediction of new chemical entities. For miRNA, there has been an increasing number of studies reported over the past decade, although not to the same degree as for transcriptomic studies. Current data suggest that it is unlikely that any gene or miRNA signature associated with short-term carcinogen exposure can replace the rodent bioassay. In this review, we discuss the application of transcriptomic and miRNA profiles to increase mechanistic understanding of chemical carcinogens and to aid in their classification.

Keywords: Liver; carcinogen; mRNA; microRNA; profiling; risk-assessment.

Publication types

  • Review

MeSH terms

  • Animals
  • Carcinogenesis / drug effects
  • Liver / drug effects*
  • Liver Neoplasms / etiology*
  • Mice
  • MicroRNAs / drug effects*
  • Rats
  • Transcriptome / drug effects

Substances

  • MicroRNAs